Scientists find new ways to convert inhibitors into degraders, paving the way for future drug discoveries 11 Apr 2024 Researchers have discovered ways to convert inhibitor-style targeted cancer drugs into small molecules known as degraders, which help destroy cancer-promoting proteins in cells. Find out more Show/Hide
ICR scientists seek new drugs to treat childhood cancer as part of global Cancer Grand Challenges team 06 Mar 2024 A global, interdisciplinary team of researchers has been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle the challenge of solid tumours in children. Find out more Show/Hide
ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs 22 Sep 2023 The Institute of Cancer Research, London, and science and technology company Merck have renewed their strategic alliance in the discovery and development of new cancer drugs. Find out more Show/Hide
ICR Discovery Club celebrates the second anniversary of the Centre for Cancer Drug Discovery 07 Nov 2022
ICR and Cancer Research UK spinout company Monte Rosa Therapeutics raises USD96m in ‘Series B’ Financing 24 Sep 2020